Evaluation of data-dependent versus targeted shotgun proteomic approaches for monitoring transcription factor expression in breast cancer

Journal of Proteome Research

Volumn 7, Issue 4, 2008, Pages 1529-1541

  Sandhu, Charanjit ^a   Hewel, Johannes A ^a   Badis, Gwenael ^a   Talukder, Shaheynoor ^a   Liu, Jian ^a   Hughes, Timothy R ^a   Emili, Andrew ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CCBR   (Canada)

Author keywords

Breast cancer; Identification; Multiple reaction monitoring; Proteomics; Tandem mass spectrometry; Transcription factor

Indexed keywords

PROTEOME; STAT1 PROTEIN; TRANSCRIPTION FACTOR; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STAT1 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA BASE; DATA DEPENDENT ANALYSIS; DISEASE COURSE; HUMAN; HUMAN CELL; ION MONITORING; MULTIPLE REACTION MONITORING; NONHUMAN; PATIENT SATISFACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RELIABILITY; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; TECHNIQUE; TREATMENT PLANNING; AMINO ACID SEQUENCE; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PATHOLOGY; TUMOR CELL LINE;

AMINO ACID SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CHROMATOGRAPHY, LIQUID; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; NF-KAPPA B P52 SUBUNIT; PROTEOMICS; RECOMBINANT FUSION PROTEINS; STAT1 TRANSCRIPTION FACTOR; TANDEM MASS SPECTROMETRY; TRANSCRIPTION FACTORS;

EID: 45549108483     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr700836q     Document Type: Article

References (59)

1. Visvader, J. E.; Lindeman, G. J. Transcriptional regulators in mammary gland development and cancer. Int. J. Biochem. Cell Biol. 2003, 35, 1034-1051.
2. Courtois, G.; Gilmore, T. D. Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene 2006, 25, 6831-6843.
3. Heusch, M.; Lin, L.; Geleziunas, R.; Greene, W. C. The generation of nfkb2 p52: mechanism and efficiency. Oncogene 1999, 18, 6201- 6208.
4. Rudolph, M. J.; Gergen, J. P. DNA-binding by Ig-fold proteins. Nat. Struct. Biol. 2001, 8, 384-386.
5. Collart, M. A.; Baeuerle, P.; Vassalli, P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF- kappa B. Mol. Cell. Biol. 1990, 10, 1498-1506.
6. Fata, J. E.; Kong, Y. Y.; Li, J.; Sasaki, T.; Irie-Sasaki, J.; Moorehead, R. A.; Elliott, R.; Scully, S.; Voura, E. B.; Lacey, D. L.; Boyle, W. J.; Khokha, R.; Penninger, J. M. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 2000, 103, 41-50.
7. Cao, Y.; Bonizzi, G.; Seagroves, T. N.; Greten, F. R.; Johnson, R.; Schmidt, E. V.; Karin, M. IKKalpha provides an essential link between RANK signaling and cyclin Dl expression during mammary gland development. Cell 2001, 107, 763-775.
8. Sovak, M. A.; Bellas, R. E.; Kim, D. W.; Zanieski, G. J.; Rogers, A. E.; Traish, A. M.; Sonenshein, G. E. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 1997, 100, 2952-2960.
9. Brantley, D. M.; Chen, C. L.; Muraoka, R. S.; Bushdid, P. B.; Bradberry, J. L.; Kittrell, F.; Medina, D.; Matrisian, L. M.; Kerr, L. D.; Yull, F. E. Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium. Mol. Biol. Cell 2001, 12, 1445-1455.
10. Connelly, L.; Robinson-Benion, C.; Chont, M.; Saint-Jean, L.; Li, H.; Polosukhin, V. V.; Blackwell, T. S.; Yull, F. E. A transgenic model reveals important roles for the NF-kappa B alternative pathway (pl00/p52) in mammary development and links to tumorigenesis. J. Biol. Chem. 2007, 282, 10028-10035.
11. Chabottaux, V.; Noel, A. Breast cancer progression: insights into multifaceted matrix metalloproteinases. Clin. Exp. Metastasis 2007, 8, 647-657.
12. Hennighausen, L.; Robinson, G. W.; Wagner, K. U.; Liu, X. Developing a mammary gland is a stat affair. J. Mammary Gland Biol. Neoplasia 1997, 2, 365-372.
13. Watson, C. J.; Miller, W. R. Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br. I. Cancer 1995, 71, 840-844.
14. Bromberg, J. F.; Wrzeszczynska, M. H.; Devgan, G.; Zhao, Y.; Pestell, R. G.; Albanese, C.; Darnell, J. E., Jr. Stat3 as an oncogene. Cell 1999, 98, 295-303.
15. Kiuchi, N.; Nakajima, K.; Ichiba, M.; Fukada, T.; Narimatsu, M.; Mizuno, K.; Hibi, M.; Hirano, T. STAT3 is required for the gpl30-mediated full activation of the c-myc gene. J. Exp. Med. 1999, 189, 63-73.
16. Jamerson, M. H.; Johnson, M. D.; Dickson, R. B. Of mice and Myc: c-Myc and mammary tumorigenesis. J. Mammary Gland Biol. Neoplasia 2004, 9, 27-37.
17. Liao, D. J.; Dickson, R. B. c-Myc in breast cancer. Endocr. Relat. Cancer 2000, 7, 143-164.
18. Butt, A. J.; McNeil, C. M.; Musgrove, E. A.; Sutherland, R. L. Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin Dl and cyclin E. Endocr. Relat. Cancer 2005, 12 (Suppl. 1), S47-59.
19. Lee, M. Y.; Joung, Y. H.; Lim, E. J.; Park, J. H.; Ye, S. K.; Park, T.; Zhang, Z.; Park, D. K.; Lee, K. J.; Yang, Y. M. Phosphorylation and activation of STAT proteins by hypoxia in breast cancer cells. Breast 2006, 15, 187-195.
20. Gutzman, J. H.; Rugowski, D. E.; Nikolai, S. E.; Schuler, L. A. Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context. Oncogene 2007, 26, 6341-6348.
21. Yu, H.; Jove, R. The STATs of cancer-new molecular targets come of age. Nat. Rev. Cancer 2004, 4, 97-105.
22. Bromberg, J. F.; Horvath, C. M.; Wen, Z.; Schreiber, R. D.; Darnell, J. E., Jr. Transcriptionally active Statl is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 7673-7678.
23. Widschwendter, A.; Tonko-Geymayer, S.; Welte, T.; Daxenbichler, G.; Marth, C.; Doppler, W. Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin. Cancer Res. 2002, 8, 3065-3074.
24. Dunn, G. P.; Ikeda, H.; Bruce, A. T.; Koebel, C.; Uppaluri, R.; Bui, J.; Chan, R.; Diamond, M.; White, J. M.; Sheehan, K. C.; Schreiber, R. D. Interferon-gamma and cancer immunoediting. Immunol. Res. 2005, 32, 231-245.
25. Shen, Y; Devgan, G.; Darnell, J. E., Jr.; Bromberg, J. F. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Statl. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 1543-1548.
26. Driouch, K.; Landemaine, T.; Sin, S.; Wang, S.; Lidereau, R. Gene arrays for diagnosis, prognosis and treatment of breast cancer metastasis. Clin. Exp. Metastasis 2007, 24, 575-585.
27. Washburn, M. P.; Wolters, D.; Yates, J. R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 19, 242-247.
28. Chen, E. I.; Hewel, J.; Felding-Habermann, B.; Yates, J. R., III. Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT). Mol. Cell. Proteomics 2006, 5, 53-56.
29. Sandhu, C.; Connor, M.; Kislinger, T.; Slingerland, J.; Emili, A. Global protein shotgun expression profiling of proliferating mcf-7 breast cancer cells. J. Proteome Res. 2005, 4, 674-689.
30. Aebersold, R.; Mann, M. Mass spectrometry-based proteomics. Nature 2003, 422, 198-207.
31. Delahunty, C.; Yates, J. R., III. Protein identification using 2D-LC-MS/MS. Methods 2005, 35, 248-255.
32. Link, A. J.; Eng, J.; Schieltz, D. M.; Carmack, E.; Mize, G. J.; Morris, D. R.; Garvik, B. M.; Yates, J. R., III. Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 1999, 17, 676-682.
33. Domon, B.; Aebersold, R. Mass spectrometry and protein analysis. Science 2006, 312, 212-217.
34. Domon, B.; Broder, S. Implications of new proteomics strategies for biology and medicine. J. Proteome Res. 2004, 3, 253-260.
35. Picotti, P.; Aebersold, R.; Domon, B. The implications of proteolytic background for shotgun proteomics. Mol. Cell. Proteomics 2007, 6, 1589-1598.
36. Kuhn, E.; Wu, J.; Karl, J.; Liao, H.; Zolg, W.; Guild, B. Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics 2004, 4, 1175-1186.
37. Anderson, L.; Hunter, C. L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 2006, 5, 573-588.
38. Kirkpatrick, D. S.; Gerber, S. A.; Gygi, S. P. The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications. Methods 2005, 35, 265-273.
39. Wolf-Yadlin, A.; Hautaniemi, S.; Lauffenburger, D. A.; White, F. M. Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 5860-5865.
40. Eng, J. K.; McCormack, A; Yates, J. R. An approach to correlate tandem mass spectral data of peptides with amino acid sequence in a protein database. J. Am. Soc. Mass Spectrom. 1994, 5, 976- 989.
41. Kislinger, T.; Rahman, K.; Radulovic, D.; Cox, B.; Rossant, J.; Emili, A. PRISM, a Generic Large Scale Proteomic Investigation Strategy for Mammals. Mol. Cell. Proteomics 2003, 2, 96-106.
42. Helbig, G.; Christopherson, K. W.; Bhat-Nakshatri, P.; Kumar, S.; Kishimoto, H.; Miller, K. D.; Broxmeyer, H. E.; Nakshatri, H. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J. Biol. Chem. 2003, 278, 21631-21638.
43. Link, A. J.; Eng, J.; Schieltz, D. M.; Carmack, E.; Mize, G. J.; Morris, D. R.; Garvik, B. M.; Yates, J. R., III. Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 1999, 17, 676-682.
44. Viatour, P.; Bentires-Alj, M.; Chariot, A.; Deregowski, V.; de Leval, L.; Merville, M. P.; Bours, V. NF- kappa B2/pl00 induces Bcl-2 expression. Leukemia 2003, 17, 1349-1356.
45. Zagouri, F.; Sergentanis, T. N.; Zografos, G. C. Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma. World J. Surg. Oncol. 2007, 5, 57.
46. Davis, M. A.; Hanash, S. High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy. Breast Cancer Res. 2006, 8, 217.
47. Song, X. C.; Fu, G.; Yang, X.; Jiang, Z.; Wang, Y.; Zhou, G. W. Protein expression profiling of breast cancer cells by dissociable antibody microarray (DAMA) staining. Mol. Cell. Proteomics 2008, 1, 163- 169.
48. Liu, H; Sadygov, R; Yates, J. R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 2004, 76, 4193-4201.
49. Venable, J. D.; Dong, M. Q.; Wohlschlegel, J.; Dillin, A.; Yates, J. R. Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra. Nat. Methods 2004, 1, 39- 45.
50. Arnott, D.; Kishiyama, A.; Luis, E. A.; Ludlum, S. G.; Marsters, J. C., Jr.; Stults, J. T. Selective detection of membrane proteins without antibodies: a mass spectrometric version of the Western blot. Mol. Cell. Proteomics 2002, 1, 148-156.
51. Purvine, S.; Eppel, J. T.; Yi, E. G; Goodlett, D. R. Shotgun collision-induced dissociation of peptides using a time of flight mass analyzer. Proteomics 2003, 3, 847-850.
52. Frewen, B. E.; Merrihew, G. E.; Wu, C. C.; Noble, W. S.; MacCoss, M. J. Analysis of peptide MS/MS spectra from large-scale proteomics experiments using spectrum libraries. Anal. Chem. 2006, 78, 5678-5684.
53. Lam, H.; Deutsch, E. W.; Eddes, J. S.; Eng, J. K.; King, N.; Stein, S. E.; Aebersold, R. Development and validation of a spectral library searching method for peptide identification from MS/MS. Proteomics 2007, 7, 655-667.
54. Craig, R.; Cortens, J. C.; Fenyo, D.; Beavis, R. C. Using annotated peptide mass spectrum libraries for protein identification. J. Proteome Res. 2006, 5, 1843-1849.
55. Craig, R.; Cortens, J. P.; Beavis, R. C. The use of proteotypic peptide libraries for protein identification. Rapid Commun. Mass Spectrom. 2005, 19, 1844-1850.
56. Barnidge, D. R.; Dratz, E. A.; Martin, T.; Bonilla, L. E.; Moran, L. B.; Lindall, A. Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. Anal. Chem. 2003, 75, 445-451.
57. Kirsch, S; Widart, J; Louette, J; Focant, J. F.; De Pauw, E. Development of and absolute quantification method targeting growth hormone biomarkers using liquid chromatography coupled to isotope dilution mass spectrometry. J. Chromatogr., A 2007, 1153 (1-2), 300-306.
58. Liu, J.; Bell, A. W.; Bergeron, J. J.; Yanofsky, C. M.; Carrillo, B.; Beaudrie, C. E.; Kearney, R. E. Methods for peptide identification by spectral comparison. Proteome Sci. 2007, 5, 3.
59. Yates, J. R., III; Morgan, S. F.; Gatlin, C. L.; Griffin, P. R.; Eng, J. K. Method to compare collision-induced dissociation spectra of peptides: potential for library searching and subtractive analysis. Anal. Chem. 1998, 70, 3557-3565.